<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2024.1478519</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Disruption of biological membranes by hydrophobic molecules: a way to inhibit bacterial growth</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Valdez-Lara</surname> <given-names>Alejandra Gabriela</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jaramillo-Granada</surname> <given-names>&#x000C1;ngela M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ortega-Zambrano</surname> <given-names>Daniel</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2822205/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Garc&#x000ED;a-Marquez</surname> <given-names>Eristeo</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1315791/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Garc&#x000ED;a-Fajardo</surname> <given-names>Jorge Alberto</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mercado-Uribe</surname> <given-names>H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ruiz-Su&#x000E1;rez</surname> <given-names>J. C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2813707/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Centro de Investigaci&#x000F3;n y de Estudios Avanzados del Instituto Polit&#x000E9;cnico Nacional Unidad Monterrey</institution>, <addr-line>Apodaca, Nuevo Le&#x000F3;n</addr-line>, <country>Mexico</country></aff>
<aff id="aff2"><sup>2</sup><institution>Centro de Investigaci&#x000F3;n y Asistencia en Tecnolog&#x000ED;a y Dise&#x000F1;o del Estado de Jalisco Subsede Noreste</institution>, <addr-line>Apodaca, Nuevo Le&#x000F3;n</addr-line>, <country>Mexico</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Krassimira Radoykova Hristova, Marquette University, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Axel Hollmann, National Scientific and Technical Research Council (CONICET), Argentina</p>
<p>Shipra Pandey, Indian Institute of Technology Bombay, India</p></fn>
<corresp id="c001">&#x0002A;Correspondence: J. C. Ruiz-Su&#x000E1;rez <email>cruiz&#x00040;cinvestav.mx</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1478519</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>08</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2025 Valdez-Lara, Jaramillo-Granada, Ortega-Zambrano, Garc&#x000ED;a-Marquez, Garc&#x000ED;a-Fajardo, Mercado-Uribe and Ruiz-Su&#x000E1;rez.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Valdez-Lara, Jaramillo-Granada, Ortega-Zambrano, Garc&#x000ED;a-Marquez, Garc&#x000ED;a-Fajardo, Mercado-Uribe and Ruiz-Su&#x000E1;rez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>With antibiotic resistance increasing in the global population every year, efforts to discover new strategies against microbial diseases are urgently needed. One of the new therapeutic targets is the bacterial cell membrane since, in the event of a drastic alteration, it can cause cell death. We propose the utilization of hydrophobic molecules, namely, propofol (PFL) and cannabidiol (CBD), dissolved in nanodroplets of oil, to effectively strike the membrane of two well-known pathogens: <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic>. First, we carried out calorimetric measurements to evaluate the effects of these drugs on model membranes formed by lipids from these bacteria. We found that the drugs modify their transition temperature, enthalpy of cohesion, and cooperativity, which indicates a strong alteration of the membranes. Then, inhibition of colony-forming units is studied in incubation experiments. Finally, we demonstrate, using atomic force and fluorescence microscopy, that the drugs, especially propofol, produce a visible disruption in real bacterial membranes, explaining the observed inhibition. These findings may have useful implications in the global effort to discover new ways to effectively combat the growing threat of drug-resistant pathogens, especially in skin infections.</p></abstract>
<kwd-group>
<kwd><italic>E. coli</italic></kwd>
<kwd><italic>S. aureus</italic></kwd>
<kwd>liposomes</kwd>
<kwd>propofol</kwd>
<kwd>CBD</kwd>
</kwd-group>
<contract-sponsor id="cn001">Consejo Nacional de Ciencia y Tecnolog&#x000ED;a<named-content content-type="fundref-id">10.13039/501100003141</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="75"/>
<page-count count="13"/>
<word-count count="8846"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>1 Introduction</title>
<p>Antimicrobial resistance (AMR) increases every day, a phenomenon that is a global health problem mainly in immunocompromised cancer patients (Bodro et al., <xref ref-type="bibr" rid="B6">2014</xref>; Gudiol and Carratal&#x000E0;, <xref ref-type="bibr" rid="B17">2014</xref>), organ transplant surgeries (Ye et al., <xref ref-type="bibr" rid="B74">2014</xref>), infections in chronic wounds (Kawano et al., <xref ref-type="bibr" rid="B22">2020</xref>), and among others (Dadgostar, <xref ref-type="bibr" rid="B11">2019</xref>). It is expected that in the serious scenario where antibiotics become ineffective, millions of deaths could produce a pre-antibiotic era (Davies and Davies, <xref ref-type="bibr" rid="B12">2010</xref>). Investigations reveal that in 2019, 1.27 million deaths were caused by antimicrobial resistance, and 4.95 million were indirectly associated with it (Murray et al., <xref ref-type="bibr" rid="B39">2022</xref>). In addition to these human losses, the Center for Disease Control and Prevention estimated that in the United States, the economic impact is 55 billion dollars per year, considering not only public health spending but also the loss of productivity (Dadgostar, <xref ref-type="bibr" rid="B11">2019</xref>). Indeed, AMR is not only an exclusive public health problem but may trigger economic consequences worldwide. If precautions are not taken, human deaths are expected to reach 10 million by 2050, resulting in a global cost of 100 billion dollars (O&#x00027;Neill, <xref ref-type="bibr" rid="B40">2016</xref>).</p>
<p>The World Health Organization (WHO) has published a list of 12 pathogens in urgent need of new antibiotics (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed">www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed</ext-link>). Unfortunately, studies on new antibiotics are scarce, as in 2020 there were only 135 preclinical projects in development worldwide (Theuretzbacher et al., <xref ref-type="bibr" rid="B65">2020</xref>).</p>
<p>It is known that the plasmatic membrane is crucial for the correct functioning of a cell (Derby and Gleeson, <xref ref-type="bibr" rid="B14">2007</xref>; De Rosa et al., <xref ref-type="bibr" rid="B13">2007</xref>; Adibhatla and Hatcher, <xref ref-type="bibr" rid="B1">2008</xref>). The membrane protects it, maintains the balance between the inside and outside, regulates cell traffic, and participates in cellular responses (Malanca and Camici, <xref ref-type="bibr" rid="B30">1989</xref>; Marza et al., <xref ref-type="bibr" rid="B32">2002</xref>; Ammendolia et al., <xref ref-type="bibr" rid="B2">2021</xref>). In eukaryotic cells, alterations in membrane fluidity have been correlated with several diseases (Shinitzky, <xref ref-type="bibr" rid="B56">1984</xref>; Sameni et al., <xref ref-type="bibr" rid="B50">2018</xref>), while in procaryotic cells, fluidization has been found to cause disruption of the cell membrane (Royce et al., <xref ref-type="bibr" rid="B45">2013</xref>). Thus, the membrane is a good target to hit because it could affect cell viability (Sudhahar et al., <xref ref-type="bibr" rid="B60">2008</xref>), particularly when mutagenic bacterial populations are confronted with new scenarios to which they are not adapted (Salinas-Almaguer et al., <xref ref-type="bibr" rid="B49">2022</xref>).</p>
<p>We propose propofol (PFL) and cannabidiol (CBD), two well-known molecules employed in many biophysics experiments to produce thermodynamic changes in lipid membranes (Momo et al., <xref ref-type="bibr" rid="B37">2002</xref>; Tsuchiya, <xref ref-type="bibr" rid="B66">2001</xref>; Perez et al., <xref ref-type="bibr" rid="B42">2022</xref>), as a way to modify the elastic properties of cellular membranes. Propofol (2,6 diisopropylphenol), a small molecule (178.2 Da), is a general anesthetic with a high partition coefficient (logP 4.16). Since it has poor aqueous solubility, propofol is normally solubilized in oils and organic solvents. On the other hand, CBD is one of the 85 components of the cannabis plant without psychoactive effects and with multiple advantages such as anti-inflammatory, appetite stimulation in AIDS, and treatment for chronic pain, depression, anxiety, psychosis, and recently, antimicrobial effects (Blaskovich et al., <xref ref-type="bibr" rid="B5">2021</xref>; Devinsky et al., <xref ref-type="bibr" rid="B15">2017</xref>; McGuire et al., <xref ref-type="bibr" rid="B33">2018</xref>). CBD is a much heavier molecule (314 Da) with a higher partition coefficient (logP 7.04).</p>
<p>In recent years, the FDA approved a new drug carrier emulsion of propofol based on soybean, but with many disadvantages such as an unstable emulsion in prolonged time and microbial contamination (Shevalkar et al., <xref ref-type="bibr" rid="B55">2019</xref>). Antimicrobial activity of CBD against <italic>N. gonorrhoeae</italic> and <italic>Moraxella catarrhalis</italic>, both Gram-negative species, was recently reported (Blaskovich et al., <xref ref-type="bibr" rid="B5">2021</xref>). The authors proposed that the effect of CBD is produced on the outer membrane of these bacteria, although they remark that the main effect is on the DNA, RNA, peptidoglycan, and lipid synthesis. In other words, they do not put any further consideration on the possible affectation of membrane integrity.</p>
<p>Due to its low water solubility and bioavailability in plasma or blood, the use of hydrophobic molecules is an interesting issue. Normally, as in the previous referred study (Blaskovich et al., <xref ref-type="bibr" rid="B5">2021</xref>), the organosulfur compound dimethyl sulfoxide (DMSO) is used to dissolve both polar and non-polar molecules, although due to its toxic effect, the concentration cannot be higher than 0.5 % v/v. In recent years, nanoemulsions, used as drug carriers, have gained relevance because they can encapsulate molecules that are poorly soluble in water (Tayeb and Sainsbury, <xref ref-type="bibr" rid="B63">2018</xref>; Li et al., <xref ref-type="bibr" rid="B26">2012</xref>; Guzm&#x000E1;n et al., <xref ref-type="bibr" rid="B18">2021</xref>; Shakeel et al., <xref ref-type="bibr" rid="B54">2012</xref>).</p>
<p>Nanoemulsions are colloidal dispersions composed of two immiscible liquids (i.e., oil-in-water or water-in-oil), with nanoscale-size droplets from 20 to 200 nm in diameter (Sagalowicz and Leser, <xref ref-type="bibr" rid="B46">2010</xref>). Their small sizes have many advantages for drug delivery due to their high bioavailability and stability for an extended time. In addition, since the drug is immersed in nanodroplets it can be preserved for large periods (Karami et al., <xref ref-type="bibr" rid="B21">2019</xref>; S&#x000E1;nchez-L0pez et al., <xref ref-type="bibr" rid="B51">2019</xref>). A previous study concluded that a nanoemulsion of herbal plant oils modified the outer membrane of Gram-positive and Gram-negative strains (Krishnamoorthy et al., <xref ref-type="bibr" rid="B24">2018</xref>). It seems that the plasma membrane, regardless of its composition, is the unspecific receptor for the molecules.</p>
<p>In this study, we investigate two pathogens that are included in the WHO list: <italic>E. coli</italic> and <italic>S. aureus</italic>. The first is a Gram-negative bacterium from the <italic>Enterobactericeae</italic> family, which shows resistance to carbapenems and also produces an extended-spectrum of beta-lactamase (ESBL). Its double lipid membrane, separated by a peptidoglycan layer, provides its protection to drugs. The second is a Gram-positive spherically shaped bacterium with a single membrane, whose natural habitat in humans is the skin and nasopharynx.</p>
<p>Before investigating the effects of PFL and CBD on <italic>E. coli</italic> and <italic>S. aureus</italic>, we performed calorimetric measurements of liposomes formed by lipids similar to those found in these bacteria. Having observed the strong effects that the aforementioned drugs produced on the membranes, we examined their effects on the growth of <italic>E. coli</italic> (K-12 MG1655) and <italic>S. aureus</italic> (Rosenbach Atcc 25923). A great correlation was found between the degree of alteration in the thermotropic profiles obtained by calorimetry and the effect on the growth of bacterial colonies. We also performed atomic force microscopy and fluorescence microscopy measurements to further evaluate the change in the morphology of the bacterial membranes.</p></sec>
<sec sec-type="materials and methods" id="s2">
<title>2 Materials and methods</title>
<sec>
<title>2.1 Reagents</title>
<p>1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) (99 %), 1,2-dipalmitoyl-sn-glycero-3-[Phospho-rac-1-glycerol] (DPPG) (99 %), 1&#x00027;,3&#x00027;-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (CL), 2,6-Diisopropylphenol (PFL) (97%), olive oil (OO) (analytic grade), and chloroform (anhydrous, &#x02265;99%, with 0.5 - 1.0% ethanol) were purchased from Sigma-Aldrich. N-octadecanoyl-D-erythro-sphingosylphosphoryl choline (sphingomyelin, brain porcine) (SM) was obtained from Avanti Polar Lipids. Texas Red dye (1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt) (TR-DHPE) was obtained from Invitrogen. Cannabidiol (CBD) (99%) (CAS: 13956-29-1) was purchased in CrescentCanna (New Orleans, USA). Very pure water (18.2 <italic>M&#x003A9;</italic>cm) was obtained from a Milli-Q IQ 7000 system.</p>
<p>The LB broth and agar (Miller) were made from casein peptone (Tryptone) (CAS: 91079-40-2), yeast extract (CAS: 8013-01-2), and sodium chloride (NaCl) (CAS: 7647-14-5), all from MCD Lab. The nutrient agar used was BD brand (SKU: 213000) and phosphate buffer (PBS, pH 7.4) (MDL: MFCD00131855).</p>
</sec>
<sec>
<title>2.2 Nanoemulsions preparation</title>
<p>CBD and PFL were separately dissolved in analytical grade olive oil (OO) to prepare stocks with a final concentration of 275 mg/mL. Thereafter, a mixture of the stocks and Milli-Q water was prepared to reach emulsions with concentrations of 1% v/v for both drugs and 3% v/v for CBD. A mixture of OO and water was prepared under the same conditions. To form the nanoemulsions, a vigorous manual agitation was first made. Then, we used a microfluidizer (Microfluidics M-110P, Massachusetts, USA) device at 100 and 150 MPa for three cycles per pressure. The temperature was controlled by adding ice to the heat exchanger container of the apparatus. Subsequently, they were stored in the fridge at 4 &#x000B0;C.</p>
</sec>
<sec>
<title>2.3 Preparation of bacteria-like membranes</title>
<p>The main lipid components of <italic>E. coli</italic> and <italic>S. aureus</italic> are the unsaturated lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-phospho-(1-rac-glycerol) sodium salt (DOPG), and cardiolipin (CL). However, since DPPE and DPPG have the same polar heads as DOPE and DOPG, we used them to prepare the needed membranes, as previously proposed by Lombardi et al. (<xref ref-type="bibr" rid="B29">2017</xref>). The idea behind this exchange is to bring the transition temperatures into a window where they are more accessible to perform the measurements (from negative temperatures approximately &#x02013;18 &#x000B0;C for the unsaturated lipids, to temperatures between 40 and 65 &#x000B0;C for the saturated ones). Two different liposomes were prepared, the first one with DPPE/DPPG (80/20 % mol), simulating the Gram-negative <italic>E. coli</italic> membrane (Lombardi et al., <xref ref-type="bibr" rid="B29">2017</xref>), and the second with DPPG/CL (95/5 % mol), mimicking the Gram-positive <italic>S. aureus</italic> membrane (Malanovic and Lohner, <xref ref-type="bibr" rid="B31">2016</xref>).</p>
<p>The liposomes were prepared at a final concentration of 5 mM. Lipids were dissolved in 1.2 mL of chloroform inside a clear amber scintillation vial. The solvent was evaporated first with a nitrogen flux and then using a degassing station (TA instruments, New Castle) at 55 &#x000B0;C for 1.5 h with agitation at 130 rpm to remove any traces of chloroform. The film was subsequently re-hydrated with Milli-Q water at 60 &#x000B0;C with agitation (230 r.p.m.) for 2 h; the final formed lipid vesicles were multilamellar vesicles (MLVs).</p>
</sec>
<sec>
<title>2.4 Sample preparation for antimicrobial activity</title>
<p>For this study, <italic>E. coli</italic> (K12-MG1655) and <italic>S. aureus</italic> (Rosenbach Atcc 25923) strains were selected and pre-inoculums cultivated in Luria-Bertani (LB) medium at 37 &#x000B0;C until an optical density (OD) of 0.4 is reached, which corresponds to the exponential growth phase. This occurs approximately in 18 h. Thereafter, a series of four dilutions is made. The first dilution was prepared with a relation of 1:100 (0.2 mL bacteria and 20 mL of LB medium). Then, three consecutive dilutions are made with a ratio of 1:1, also incubated and mixed until the same absorbance (0.4 OD) is obtained. The last dilution was centrifuged at 4,000 r.p.m. for 10 min; then, the supernatant is eliminated, and the pellet was recuperated and re-suspended in a 10 mM phosphate buffer saline (PBS). This is repeated three consecutive times.</p>
</sec>
<sec>
<title>2.5 Differential scanning calorimetry</title>
<p>A total of 500 &#x003BC;L of large unilamellar vesicles (LUVs) and 500 &#x003BC;L of the nanoemulsion were mixed for a total of 3.7 mg/mL lipid concentration and 2.75 mg/mL (1% v/v) or 8.25 mg/mL (3% v/v) of the drug (PFL or CBD). Then, all of the samples stayed at room temperature for 15 min and degassed at &#x02013;635 mmHg before calorimetric analysis in a differential scanning calorimeter (Nano DSC, TA Instruments, New Castle). Each sample was scanned in heating mode. After 600 s of equilibrium time, the profile was recorded at a rate of 1 &#x000B0;C/min and cell pressure of 3 bar. Three independent experiments were performed.</p>
</sec>
<sec>
<title>2.6 Characterization of nanoemulsions</title>
<p>Dynamic light scattering (DLS) was used to determine the size distribution of the nanoemulsions. They were diluted by 10x before carrying out size and zeta potential measurements in a zeta sizer (Nano ZSP, Malvern Instruments, United Kingdom). The laser wavelength and detector angle location were 633 nm and 173&#x000B0;, respectively. The instrument recorded intensity fluctuations, which were then analyzed using the Stokes-Einstein equation <italic>R</italic> &#x0003D; <italic>K</italic><sub><italic>B</italic></sub><italic>T</italic>/6&#x003C0;<italic>&#x003B7;D</italic>, with R, <italic>K</italic><sub><italic>B</italic></sub>, T, &#x003B7;, and D being the hydrodynamic radius, Boltzmann constant, temperature, dynamic viscosity, and diffusion coefficient, respectively. Zeta potential was calculated from the electrophoretic mobility employing Smoluchowski equation &#x003BC; &#x0003D; &#x003F5;&#x003B6;/&#x003B7;, where &#x003F5; is the dielectric constant and &#x003B7; the dynamic viscosity. All measurements were conducted at 25&#x000B0;C, and each measurement was repeated at least three times &#x000B0;C.</p>
</sec>
<sec>
<title>2.7 Colony-forming unit assay</title>
<p>To find the amount of dead cells, four dilution series are performed 1:10 (100 &#x003BC;L suspended bacteria and 900 &#x003BC;L nanoemulsion) for each case (OO 1% v/v, OO 3% v/v, CBD-OO 1 and 3% v/v, and PFL-OO 1 % v/v). Next, an aliquot of 100 &#x003BC;L was placed in the petri dish, to spread it evenly across the surface of the LB agar. The cultures were incubated for 12 h at 37&#x000B0;C. The countable ranges were between 20 and 200 colonies per plate. Each sample was observed in triplicate (three plates were used to incubate and then the colonies counted) to ensure accuracy and reliability of the results. Finally, the number of formed colonies was registered.</p>
</sec>
<sec>
<title>2.8 Minimal inhibitory concentration</title>
<p>MIC was done for both cultures. A concentration scan is carried out, considering 8, 16, 100, 300, 1,000, and 2,750 &#x003BC;g/mL of PFL-OO and PFL-DMSO [maximal volume (0.5% v/v)], and OO with no drug were added to 1 mL of bacteria culture at the beginning of the exponential growth phase, approximately 1 &#x000D7; 10<sup>8</sup> CFU/mL of cell density (Optical density of 0.02 A.U. at 600 nm). Then, in a broth plate with 96 wells, it was added 100 &#x003BC;L of bacterial culture with different concentrations of drugs and then incubated at 37&#x000B0;C for 12 h with gentle shaking. MIC values were obtained by measuring optical density at 600 nm to determine changes in turbidity.</p>
</sec>
<sec>
<title>2.9 Atomic force microscopy</title>
<p>Three samples of bacteria culture were cultivated independently with propofol at 2.75 mg/mL (final concentration). DMSO at 0.5% v/v was used as a carrier. Here, it is important to mention that, to correctly perform the AFM experiments, the carrier was changed because the oil nanodroplets stuck on the cantilver making the measurements difficult. This inconvenient did not show up when using DMSO. Since it was proved that the obtained effects are produced by the drug, nor by the carrier (see below), DMSO was a good choice. Bacteria strains were grown for 2 h at 37&#x000B0;C with 130 r.p.m., and then, 10 mL of cells were centrifuged at 4,000 r.p.m. for 10 min. The pellet was re-suspended in 10 mL of PBS buffer and centrifuged at 4,000 r.p.m. for 10 min, for three times. Finally, another three washes with deionized water were performed. 10 &#x003BC;L of each solution was poured onto a glass cover slip previously treated with 0.1% w/v poly-l-lysine. The drops were allowed to dry overnight to be measured the next day.</p>
<p>Measurements were made with an atomic force microscope (Innova Bruker, Santa Barbara, CA). The cantilever MSNL-10 was used. The tip spring constant was 0.03 N/m which has a resonant frequency around 15 kHz and radius of 2 nm. The images were taken in contact mode with a resolution and scan rate of 512 &#x000D7; 512 pixels and 3 Hz, respectively. The set points were: 4 V (for <italic>E. coli</italic>) and 2 V (for <italic>S. aureus</italic>), with proportional-integral-derivative (PID) parameters: 3,1,1. All measurements were performed at room temperature. Image processing was done using the Gwyddion 2.62 software.</p>
</sec>
<sec>
<title>2.10 Fluorescence microscopy</title>
<p>Three samples of bacteria culture were cultivated independently with propofol at 2.75 mg/mL (final concentration). DMSO at 0.5% v/v was also used as a carrier to avoid any interference with the measurements. Bacterial strains were grown for 2 h at 37&#x000B0;C and 130 r.p.m.; then, 10 mL of cells were centrifuged at 4,000 r.p.m. for 10 min. The pellet was re-suspended in 10 mL of PBS buffer and centrifuged at 4,000 r.p.m. for 10 min. This maneuver was done three times. Finally, another three washes with deionized water were performed. 200 &#x003BC;L of each solution was mixed with 10 &#x003BC;L of TR-DHPE (100 &#x003BC;g/mL); then, all solutions were incubated for 1.5 h in darkness at room temperature. An inverted fluorescence microscope (Axio Observed.Z1, Zeiss, Germany) was used to observe the interaction between the bacterial cell membrane and TR-DHPE dye. The filter used for TR-DHPE dye was L50 Cy5. Pixel sizes for the image are 4.54 &#x000D7; 4.54 &#x003BC;m, mode resolution 2,752 &#x000D7; 2,208, and exposure time of 600 ms. The images were processed using ZEN 2 Pro software.</p>
</sec>
<sec>
<title>2.11 Statistics</title>
<p>Three independent experiments with three replicates each were carried out. The replicates were averaged, and the resulting averages were subjected to the Shapiro&#x02013;Wilk test to assess the normality of the distributions. The Shapiro&#x02013;Wilk test revealed that the distributions were not normal. Therefore, we used the Wilcoxon rank test to determine significant differences between controls and experiments. The asterisk indicates a significant difference with a p-value &#x02264; 0.1.</p></sec></sec>
<sec id="s3">
<title>3 Results and discussion</title>
<p>Before starting the experiments with the mentioned drugs, the stability of the nanoemulsions is verified by obtaining their size distributions and zeta potentials using dynamic light scattering (see details in Section 2.6). The suspensions were diluted by 10x before the measurements, to protect the electrodes of the zeta potential cells.</p>
<p>All the size distributions of the nanodroplets were predominantly centered at approximately 50 nm (<xref ref-type="fig" rid="F1">Figure 1A</xref>) and maintained their sizes for at least 15 days, which was enough time to perform the experiments (see <xref ref-type="fig" rid="F1">Figure 1B</xref>). The negative zeta potential is the reason why coalescence is negligible (the droplets repel each other by an electrostatic force) (see <xref ref-type="fig" rid="F1">Figure 1C</xref>). To explain the origin of the negative charge of the droplets, let us remember that olive oil is a composition of fatty acids such as linoleic, stearic, palmitic, and linolenic acids (Boskou et al., <xref ref-type="bibr" rid="B7">2006</xref>). Since the pK of the carboxyl groups contained in their structure is very low (approximately 3.5), and the continuum phase of the nanoemulsion is deionized water (pH approximately 6), deprotonation occurs, being the cause of the negative z potential (Yang et al., <xref ref-type="bibr" rid="B72">2013</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Characterization of the nanoemulsions through <bold>(A)</bold> size distribution, <bold>(B)</bold> kinetic stability, and <bold>(C)</bold> Zeta potential of the particles. The particle sizes and electric charge are very stable. Effects of nanoemulsions on liposomes using DSC: calorimetric profiles of <italic>E. coli</italic> <bold>(D)</bold> and <italic>S. aureus</italic> <bold>(E)</bold>-like-membranes. In both cases, PFL-OO 1% v/v has the greatest effect in the modification of cooperativity and transition temperature T<sub><italic>m</italic></sub> with respect to the controls (black lines of profiles of pure liposomes) (see <xref ref-type="table" rid="T1">Table 1</xref>). Chemical structures of the evaluated drugs: propofol and CBD <bold>(F)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-15-1478519-g0001.tif"/>
</fig>
<p>By evaluating the effect of the nanoemulsions on the model membrane of PE/PG as a <italic>E. coli</italic>-like-membrane and PG/CL as a <italic>S. aureus</italic>-like-membrane, it was noted that, compared to the calorimetric profiles of the control, the olive oil nanocarriers either produced a small shift to higher temperatures (due to the inclusion of the fatty acids in the membrane that increases molecular packing and therefore stiffness) (<xref ref-type="fig" rid="F1">Figure 1D</xref>, or did not so, <xref ref-type="fig" rid="F1">Figure 1E</xref>, see <xref ref-type="table" rid="T1">Table 1</xref>). Therefore, it can be presumed that they are harmless to the profiles and good choices for preparing the nanoemulsions. Indeed, the effects of PFL-OO and CBD-OO (1% v/v), and CBD-OO (3% v/v) are clearly opposite: The profiles stretch, deform, and shift at lower temperatures, indicating strong fluidization and loss of membrane cooperativity (<xref ref-type="fig" rid="F1">Figures 1D, E</xref>). The shoulders in the profiles are associated with a phase separation due to the presence of different domains, regions where the drugs have not been distributed homogeneously (Korkmaz and Severcan, <xref ref-type="bibr" rid="B23">2005</xref>). Although both drugs strongly affect the thermodynamic properties of the vesicles, and therefore compromised the integrity of the membranes, it is remarkably that PFL-OO 1% v/v has a stronger effect than CBD-OO 3% v/v. In fact, PFL-OO 1% v/v moved the T<sub><italic>m</italic></sub> 5&#x000B0;C more than CBD-OO at 3% v/v (see <xref ref-type="table" rid="T1">Table 1</xref>). The widths of the profiles shown in <xref ref-type="fig" rid="F1">Figures 1D, E</xref> were obtained by the standard deviations of three repetitions.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Transition temperatures (temperatures of main peaks) and enthalpies (areas under the curves), with standard deviations, obtained from DSC profiles.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#8f9496;color:#ffffff">
<th/>
<th valign="top" align="center"><bold>Enthalpy (kJ/mol)</bold></th>
<th valign="top" align="center"><bold>STD</bold></th>
<th valign="top" align="center"><bold>Tm (&#x000B0;C)</bold></th>
<th valign="top" align="center"><bold>STD</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#dee1e1;">
<td valign="top" align="left" colspan="5"><italic><bold>E. coli</bold></italic> <bold>membrane-like lipids</bold></td>
</tr> <tr>
<td valign="top" align="left">Control</td>
<td valign="top" align="center">79.19</td>
<td valign="top" align="center">3.51</td>
<td valign="top" align="center">63.77</td>
<td valign="top" align="center">0.45</td>
</tr> <tr>
<td valign="top" align="left">OO 1%</td>
<td valign="top" align="center">27.20</td>
<td valign="top" align="center">3.78</td>
<td valign="top" align="center">64.53</td>
<td valign="top" align="center">0.65</td>
</tr> <tr>
<td valign="top" align="left">OO 3%</td>
<td valign="top" align="center">16.92</td>
<td valign="top" align="center">1.19</td>
<td valign="top" align="center">64.40</td>
<td valign="top" align="center">1.14</td>
</tr> <tr>
<td valign="top" align="left">CBD-OO 1%</td>
<td valign="top" align="center">43.22</td>
<td valign="top" align="center">7.25</td>
<td valign="top" align="center">62.97</td>
<td valign="top" align="center">0.89</td>
</tr> <tr>
<td valign="top" align="left">CBD-OO 3%</td>
<td valign="top" align="center">21.34</td>
<td valign="top" align="center">0.72</td>
<td valign="top" align="center">63.12</td>
<td valign="top" align="center">0.17</td>
</tr> <tr>
<td valign="top" align="left">PFL-OO 1%</td>
<td valign="top" align="center">46.73</td>
<td valign="top" align="center">2.64</td>
<td valign="top" align="center">59.12</td>
<td valign="top" align="center">0.51</td>
</tr> <tr>
<td valign="top" align="left">PFL-DMSO 1%</td>
<td valign="top" align="center">40.54</td>
<td valign="top" align="center">0.74</td>
<td valign="top" align="center">62.42</td>
<td valign="top" align="center">1.64</td>
</tr> <tr style="background-color:#dee1e1;">
<td valign="top" align="left" colspan="5"><italic><bold>S. aureus</bold></italic> <bold>membrane-like lipids</bold></td>
</tr> <tr>
<td valign="top" align="left">Control</td>
<td valign="top" align="center">42.79</td>
<td valign="top" align="center">9.26</td>
<td valign="top" align="center">46</td>
<td valign="top" align="center">0.42</td>
</tr> <tr>
<td valign="top" align="left">OO 1%</td>
<td valign="top" align="center">36.82</td>
<td valign="top" align="center">1.63</td>
<td valign="top" align="center">46.31</td>
<td valign="top" align="center">0.54</td>
</tr> <tr>
<td valign="top" align="left">OO 3%</td>
<td valign="top" align="center">39.38</td>
<td valign="top" align="center">0.28</td>
<td valign="top" align="center">49.28</td>
<td valign="top" align="center">0.09</td>
</tr> <tr>
<td valign="top" align="left">CBD-OO 1%</td>
<td valign="top" align="center">39.11</td>
<td valign="top" align="center">0.11</td>
<td valign="top" align="center">43.93</td>
<td valign="top" align="center">0.08</td>
</tr> <tr>
<td valign="top" align="left">CBD-OO 3%</td>
<td valign="top" align="center">39.92</td>
<td valign="top" align="center">0.12</td>
<td valign="top" align="center">43.35</td>
<td valign="top" align="center">0.23</td>
</tr> <tr>
<td valign="top" align="left">PFL-OO 1%</td>
<td valign="top" align="center">33.79</td>
<td valign="top" align="center">5.94</td>
<td valign="top" align="center">36.55</td>
<td valign="top" align="center">0.18</td>
</tr>
<tr>
<td valign="top" align="left">PFL-DMSO 1%</td>
<td valign="top" align="center">40.77</td>
<td valign="top" align="center">3.01</td>
<td valign="top" align="center">33.30</td>
<td valign="top" align="center">0.24</td>
</tr></tbody>
</table>
</table-wrap>
<p>To illustrate the calorimetric changes described above using a simplistic scheme, the cartoon depicted in <xref ref-type="fig" rid="F2">Figure 2</xref> may be useful. Indeed, the observed changes in the cohesion enthalpies produced by the drugs give rise to a general disorder in the membranes.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Schematic representation of the hydrophobic drug effects on the liposome model and bacterial membrane. The <bold>top</bold> panels depict a lipid vesicle before and after the drug insertion, and the <bold>lower</bold> panel schematizes a Gram-negative bacteria under such conditions.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-15-1478519-g0002.tif"/>
</fig>
<p>It is important to remark that the effects generated by CBD and PFL (see their molecular structures in <xref ref-type="fig" rid="F1">Figure 1F</xref>) on both PE/PG and PG/CL are driven by enthalpic and entropic forces. This indicates that the intrusion of external molecules into the bilayer affects the cohesive energy. Since the 1% v/v and 3% v/v nanoemulsions in the vesicle suspensions corresponded to 2.75 mg/mL (1% v/v) or 8.25 mg/mL (3% v/v), respectively, propofol has a higher number of molecules owing to its lower molecular weight, which could explain its stronger effect on the membrane integrity. However, it is important to note that these concentrations translate into 15.42 mM for PFL-OO (1% v/v), and 8.74 and 26.22 mM for CBD-OO (1% v/v and 3% v/v), respectively. As a result, the amount of molecules is not the unique reason for its greater effect. In addition, since CBD is much more hydrophobic than PFL, hydrophobicity is not the reason for the effect either.</p>
<p>The disrupting effect of PFL has been widely studied before (P&#x000E9;rez-Isidoro et al., <xref ref-type="bibr" rid="B43">2014</xref>; Paiva et al., <xref ref-type="bibr" rid="B41">2012</xref>). Dynamic molecular simulations revealed that PFL exhibits a preference for localizing near the hydrocarbons tails of the phospholipids (Hansen et al., <xref ref-type="bibr" rid="B19">2013</xref>). There, the hydroxyl group of the propofol interacts with their ester oxygens, generating perturbations that cause the lipids to go through the gel-liquid phase with less energy. Similarly, the CBD molecule contains two hydroxyl groups that can interact with the ester oxygen, and the rest of the molecule is oriented toward the hydrophobic region. Furthermore, it is important to note that the drugs were carried by nanodroplets. Consequently, adding hydrophobic molecules to the dispersed phase (olive oil) prevents them from dissolving in the continuous phase (water). Yet, PFL could diffuse better than CBD to reach the lipid bilayer. In addition, it has been shown that, despite being more soluble in octanol and therefore more likely to diffuse into lipid membranes, molecules with logP greater than 5 have reduced penetration in cells (Lipinski et al., <xref ref-type="bibr" rid="B28">2012</xref>).</p>
<p>If a simple membrane model like the one discussed above undergoes a significant change in its structural condition when interacting with PFL and CBD, which completely modify the transition temperature and enthalpy of cohesion, as shown in <xref ref-type="fig" rid="F1">Figures 1D, E</xref>, a biological membrane may also suffer similar modifications in its membrane integrity, compromising the organism viability (see <xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>To test this hypothesis, the effect of the nanoemulsion on both bacteria was evaluated by assessing the growth behavior of colonies in agar plates. This assay consisted in proving first the harmless effect of the vehicle and then performing independent test of the bactericide effects of the drugs (see <xref ref-type="fig" rid="F3">Figures 3A, B</xref>). To see whether the incubation time was an important factor, the CFU was measured at different periods of time. It is clear that propofol, prepared at 1% v/v concentration, has a fully annihilation effect in <italic>E. coli</italic> after 10 h and in <italic>S. aureus</italic> after 8 h. On the other hand, CBD at 1% v/v produced only a mild inhibition effect on the growth of bacteria compared to the control, but at 3% v/v reduced a bit more than two decades in a log scale, which means a drop in viability better than 99%.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Effect of various agents on <italic>E. coli</italic> and <italic>S. aureus</italic> bacteria with a final concentration of 24&#x02013;10<sup>8</sup> CFU/mL (Optical density of 0.04 A.U. at 600 nm). <bold>(A)</bold> For <italic>E. coli</italic>, we show that the vehicles (OO 1% v/v and OO 3% v/v) have the same small effect. Propofol-OO has a full bactericide effect, while CBD-OO needs to be augmented to 3% v/v to give rise to a 99% in the decrease of viability (2log reduction). In the vertical scale, &#x02013;1 indicates that no bacteria survived after 10 h. <bold>(B)</bold> For <italic>S. aureus</italic>, the antimicrobial effectiveness of propofol is even better since &#x02013;1 is obtained at 8 h. The minimum inhibitory concentration (MIC) of nanoemulsions (OO and PFL-OO) and PLF-DMSO was found in both bacteria after 12 h of cell culture growth <bold>(C, D)</bold>. Three independent experiments were performed in our experiments. The median and the interquartile values in the error bars are shown. Asterisks mean the difference statistics tested with the Wilcoxon rank.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-15-1478519-g0003.tif"/>
</fig>
<p>Our findings contrast with previous studies on propofol emulsions, where it has been reported that they promote bacterial growth when dissolved in soybean oil. Hence, it seems that nanoemulsions are susceptible to contamination (Baker et al., <xref ref-type="bibr" rid="B3">2005</xref>). For such a reason, efforts to reformulate the colloidal suspensions have been undertaken, for example, the use of other oily vehicles and/or the addition of ethylenediaminetetraacetic acid (EDTA) (Sakuragi et al., <xref ref-type="bibr" rid="B47">1999</xref>; Wang et al., <xref ref-type="bibr" rid="B69">2007</xref>; Shevalkar et al., <xref ref-type="bibr" rid="B55">2019</xref>). In contrast, our results showed that, carried by olive oil nanodroplets, PFL at 1% v/v strongly inhibits the growth of <italic>E. coli</italic> and <italic>S. aureus</italic> bacteria.</p>
<p>Some action mechanisms have been studied for the bactericidal action of hydrophobic molecules (Blaskovich et al., <xref ref-type="bibr" rid="B5">2021</xref>). It is proposed that one of the potential unexplored targets could be the composition of the outer lipid bilayer because the membrane is the first component found between the extracellular medium and the cells. Indeed, to understand our findings beyond the usual conception behind antibiotic strategies, which are mostly based on attacking specific biochemical targets, or in creating membrane pores that shortcut the membrane potential, it is important to discuss a recent paper by some of us (Salinas-Almaguer et al., <xref ref-type="bibr" rid="B49">2022</xref>). It was studied the effect produced by pentanol as a membrane softening by bilayer disruption. Similar to the damage produced by fluidization (Royce et al., <xref ref-type="bibr" rid="B45">2013</xref>), or lethal permeability upsurge (Vaara, <xref ref-type="bibr" rid="B67">1992</xref>), it is shown that, after a long induction phase in which the microorganisms are striving against a bacteriostatic action, the cells cannot proliferate due to lipid packing distortion which results in further delocalization of membrane proteins impairing multiple essential processes including respiration (Strahl and Hamoen, <xref ref-type="bibr" rid="B59">2010</xref>), nucleotide synthesis (Wenzel et al., <xref ref-type="bibr" rid="B70">2014</xref>), FtsZ assembly (Silber et al., <xref ref-type="bibr" rid="B57">2020</xref>; Mileykovskaya et al., <xref ref-type="bibr" rid="B35">1998</xref>), and nucleoid segregation (Mileykovskaya et al., <xref ref-type="bibr" rid="B35">1998</xref>; Chai et al., <xref ref-type="bibr" rid="B9">2014</xref>), with the collateral effect to harm the cytokinetic apparatus so as to prevent and/or delay the membrane constriction need for normal cell division and offspring generation. In summary, a membrane disruptor such as pentanol, or propofol, compromises the crucial role of membrane rigidity as the key regulator of bacterial proliferation. Other studies of essential oil nanoemulsions have found toxic effects on bacteria (Moghimi et al., <xref ref-type="bibr" rid="B36">2016</xref>; Dons&#x00301;&#x00131; et al., <xref ref-type="bibr" rid="B16">2012</xref>; Terjung et al., <xref ref-type="bibr" rid="B64">2012</xref>), although the mechanisms involved are attributed to perturbation and cellular leakage caused by the hydrophobic components of the nanodroplets (Seow et al., <xref ref-type="bibr" rid="B53">2014</xref>).</p>
<p>As above mentioned, since PFL is much less hydrophobic than CBD, it can be more easily solubilized in the medium. After the exogenous molecules are internalized in the membrane, they alter its correct functioning. The greater their ability to diffuse in the membrane, the greater the cellular damage inflicted.</p>
<p>Since it is crucial to investigate whether a lower dose could give similar results in terms of bacterial inhibition, experiments to find the minimal inhibitory concentration (MIC) were performed. First, the results show that the most effective carrier was PFL-OO, compared to PFL-DMSO (see <xref ref-type="fig" rid="F3">Figures 3C, D</xref>). Second, the MIC sensitivity in both bacteria was 300 &#x003BC;g after 12 h of incubation, much lower than the concentration used above in the CFU assay (2.75 mg/mL). Let us remark though that MIC assays are performed in liquid media Luria-Bertani (LB) Broth and the CFUs on LB agar.</p>
<p>As a crucial probe to confirm that the morphology of bacteria after the treatment is similar to the one depicted in <xref ref-type="fig" rid="F2">Figure 2</xref>, AFM images were captured as shown in <xref ref-type="fig" rid="F4">Figure 4</xref>. Let us remark that we focused only on the effect produced by propofol, which was the drug that produced the greatest effects on the viability of the organisms.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><italic>E. coli</italic> and <italic>S. aureus</italic> top images obtained by AFM. <bold>(A, E)</bold> with no treatment (controls), <bold>(B, F)</bold> with DMSO at 0.5%, and <bold>(C, G)</bold> with DMSO/PFL; <italic>E. coli</italic> and <italic>S. aureus</italic>, respectively. The images illustrate the dramatic damages caused in the cell membranes by PFL. Lengths and widths of the cells: for <italic>E. coli</italic> <bold>(D)</bold> and for <italic>S. aureus</italic> <bold>(H)</bold>. In the case of <italic>E. coli</italic>, the histograms were obtained from 21 (no treatment), 43 (DMSO), and 27 (PFL) cells. For <italic>S. aureus</italic>, the histograms were calculated from 39 (no treatment), 25 (DMSO), and 25 (PFL) cells.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-15-1478519-g0004.tif"/>
</fig>
<p>In <xref ref-type="fig" rid="F4">Figures 4A, E</xref>, it is observed the typical rod-shaped and spherical structures of <italic>E. coli</italic> and <italic>S. aureus</italic>, whose average sizes are shown in <xref ref-type="fig" rid="F4">Figures 4D, H</xref>, which is in agreement with previous reports (Meincken et al., <xref ref-type="bibr" rid="B34">2005</xref>; Yao et al., <xref ref-type="bibr" rid="B73">2012</xref>; Harris and Theriot, <xref ref-type="bibr" rid="B20">2016</xref>). Likewise, the cells with DMSO did not exhibit great deformations on their membranes, indicating that DMSO (0.5% v/v) was not harmful (see <xref ref-type="fig" rid="F5">Figures 5B</xref>, <xref ref-type="fig" rid="F5">F</xref>). It is important to remark that the growth of the colonies in the experiments reported in <xref ref-type="fig" rid="F3">Figure 3</xref> was not assessed, not only because so little concentration of DMSO is innocuous (Lim et al., <xref ref-type="bibr" rid="B27">2012</xref>; Summer et al., <xref ref-type="bibr" rid="B61">2022</xref>), but also because the evolution of the optical density for both bacteria, with and without DMSO, was the same.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Contact-mode height AFM images of <italic>E. coli</italic> and <italic>S. aureus</italic>. <bold>(A, D)</bold> Show control cells, <bold>(B, E)</bold> after treatment with DMSO at 0.5%, and <bold>(C, F)</bold> after DMSO/PFL treatment, <italic>E. coli</italic>, and <italic>S. aureus</italic>, respectively. The first column corresponds to 3D topographic images, the second corresponds to 2D, and the third column corresponds to the height and size measurement of the selected cross-sectional line of the image. Black, green, and red lines are repetitions for three different bacteria. Despite the dispersion, it is clear the effect of PFL.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-15-1478519-g0005.tif"/>
</fig>
<p>The cells with PFL were notoriously different, as observed in <xref ref-type="fig" rid="F4">Figures 4C, G</xref>. It is obvious that these changes in the membrane compromise the viability of the cells, explaining the results shown in <xref ref-type="fig" rid="F3">Figure 3</xref>. Therefore, the mechanistic reason for bacterial death is simply that this hydrophobic molecule completely affects the entire membrane, inflicting drastic damages in the regulation of bacterial proliferation.</p>
<p>It is enthralling that <italic>S. aureus</italic> bacteria treated with DMSO/PFL not only lose the spherical morphology but also give rise to small vesicles not observed in the control sample, probably due to homeostatic and stressful conditions. Indeed, to combat stressors and survive, pathogens have established various defensive mechanisms, and one of them is the production of membrane vesicles (Mozaheb and Mingeot-Leclercq, <xref ref-type="bibr" rid="B38">2020</xref>).</p>
<p><xref ref-type="fig" rid="F5">Figure 5</xref> shows topographic images corresponding to <xref ref-type="fig" rid="F4">Figure 4</xref>. It is clear the expected shape of both bacteria in A, B, D, and E (Chang and Liu, <xref ref-type="bibr" rid="B10">2018</xref>; Salinas-Almaguer et al., <xref ref-type="bibr" rid="B48">2015</xref>; Whitehead et al., <xref ref-type="bibr" rid="B71">2006</xref>). Next, it is shown that PFL produces height irregularities in <italic>E. coli</italic> (C) and <italic>S. aureus</italic> (F). The side profile along the length of the bacterium, as shown in the second column, is consistent with such 3D images. The height (Z) profiles from the organisms are seen in the last column, which indicates a non-random behavior. Note the dramatic change in the topography of the cell membrane with PFL treatment along the cross section, which modifies shape and height. It is worth mentioning that the very low concentration found in our MIC experiments could produce damage to the bacteria membranes in the same way as those shown in <xref ref-type="fig" rid="F4">Figure 4</xref>, although not necessarily observable with the sensitivity of our AFM.</p>
<p>As a final test to evaluate bacterial membrane damage caused by PFL, it was performed fluorescence microscopy measurements, using a phosphoethanolamine dye (TR-DHPE), which is employed as an indicator for liquid disordered membranes (Krivic et al., <xref ref-type="bibr" rid="B25">2022</xref>; Skaug et al., <xref ref-type="bibr" rid="B58">2011</xref>; Baumgart et al., <xref ref-type="bibr" rid="B4">2007</xref>; Veatch and Keller, <xref ref-type="bibr" rid="B68">2005</xref>). We evaluated the effect in both culture strains (see <xref ref-type="fig" rid="F6">Figure 6</xref>). Brightfield and fluorescence images are depicted. It is clear that the dye diffuses in both bacteria only when they are treated with PFL, although in the case of <italic>S. aureus</italic>, the dye penetration is stronger. Even in the absence of PFL (empty DMSO carrier), the dye diffuses a little. This observation is consistent with the fact that <italic>S. aureus</italic> does not have an additional barrier. Furthermore, this also explains the greater inhibition produced by PFL for the Gram-positive bacteria (see <xref ref-type="fig" rid="F3">Figures 3A, B</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Fluorescence images of the effects of propofol on the bacterial membrane of <italic>E. coli</italic> and <italic>S. aureus</italic> cultures after 1.5 h treatment. The red fluorescence indicates that the phospholipid (TR-DHPE) penetrates the cell membranes. Clearly, in both cases, inward diffusion is promoted by the membrane disruption caused by propofol. Three groups are shown: control, drug carrier (DMSO), and drug (PFL). A 40X objective was used.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-15-1478519-g0006.tif"/>
</fig>
<p>It is important to note before closing that the research we report here is not the first to explore the promising idea that hydrophobic drugs can be used as a treatment against bacteria. In fact, growth inhibition has been reported to occur for <italic>S. epidermidis, S. pyogenes</italic>, and <italic>S. pneumoniae</italic> with 2.5 mg/mL of the local anesthetic bupivacaine (Rosenberg and Renkonen, <xref ref-type="bibr" rid="B44">1985</xref>). Furthermore, it has been shown that nanoemulsions can significantly improve the efficacy of the hydrophobic drugs delivery, as demonstrated with the carbapenem-resistant <italic>K. pneumoniae</italic> (Tayeb et al., <xref ref-type="bibr" rid="B62">2022</xref>). However, to the best of our knowledge, our study is the first to explore pathogen membrane destabilization upon insertion of hydrophobic drugs. We found that PFL has a remarkable effect in this regard.</p>
<p>To put our findings in perspective, we claim that PFL, and to a lesser extent CBD, could have enormous potential in skin infections where antimicrobial resistance is already a medical problem. In fact, despite recent advances in wound treatment, very few topical therapies have proven effective in promoting wound healing, especially because when recalcitrant bacteria invade wounds, they create a cytotoxic environment that often promotes very serious injuries (Kawano et al., <xref ref-type="bibr" rid="B22">2020</xref>). Furthermore, it is worth mentioning that the method proposed here could be combined with other strategies to improve effectiveness. For example, since essential oils have been found to enhance the antimicrobial activity of drugs and also inhibit the transmission of resistance to other populations (Bueno, <xref ref-type="bibr" rid="B8">2016</xref>), our nanoemulsions could be used in combination with antibiotics or antimicrobial peptides (AMP). Clearly, they could act as adjuvants to increase the uptake of the antibiotic through the bacterial membrane in topical applications. The absorption of PFL through the skin, if it occurs, would not be a problem, since the concentration used here (2.75 mg/mL) is less than the injectable dose normally administered during anesthesia (Sch&#x000FC;ttler and Ihmsen, <xref ref-type="bibr" rid="B52">2000</xref>). In fact, for a person who weighs approximately 70 kg, the propofol infusion rate is between 2 and 4 mg/mL per minute, for not less than 60 min (time for rapid surgery). This is equivalent to at least 120 mg. Furthermore, recent investigations on the anesthetic effects of propofol through skin absorption found that this drug may have a potential use in clinical practice, especially in pediatric applications (Zhang et al., <xref ref-type="bibr" rid="B75">2021</xref>), where the concentrations used are approximately 10 mg/mL. Concomitantly, this transdermal way of administering propofol gels implies safety for cutaneous/topical applications.</p>
<p>Two limitations of this study are the unexpected poor outcome of CBD and the absence of evidence on the possible medical application of our findings. As we expected the more hydrophobic CBD to give better results but it did not, we would like to provide a positive electrical charge to the nanodroplets and make the release of the drug into the bacterial membranes, which have a negative charge, more efficient. In addition, we would like to test PFL in model animal infections. Such a strategy could provide us with important information about medical applications in humans, to try to contribute to the imminent health emergency that is approaching.</p></sec>
<sec sec-type="conclusions" id="s4">
<title>4 Conclusion</title>
<p>In the present study, hydrophobic nanoemulsions based on olive oil as potential inhibitors of bacterial growth were investigated. We found that propofol has a greater effect than CBD to annihilate bacteria, owing to its property to alter their membrane integrity. Beyond their ability of survival, the pathogens cannot cope with the stress produced by hydrophobic molecules that diffuse in their membranes compromising the cells to proliferate. This study could help in the search for new antimicrobial drugs whose action is neither selective nor on a specific target but directed non-specifically at cell membranes.</p></sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The manuscript presents research on animals that do not require ethical approval for their study.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>AV-L: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing, Data curation, Investigation, Software, Validation. &#x000C1;J-G: Data curation, Investigation, Software, Validation, Writing &#x02013; original draft, Methodology, Writing &#x02013; review &#x00026; editing. DO-Z: Data curation, Investigation, Methodology, Writing &#x02013; original draft, Conceptualization, Formal analysis, Writing &#x02013; review &#x00026; editing. EG-M: Methodology, Writing &#x02013; original draft, Resources, Supervision, Writing &#x02013; review &#x00026; editing. JG-F: Methodology, Resources, Supervision, Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft. HM-U: Methodology, Resources, Supervision, Writing &#x02013; review &#x00026; editing, Funding acquisition, Investigation, Visualization, Writing &#x02013; original draft. JR-S: Methodology, Funding acquisition, Resources, Supervision, Writing &#x02013; review &#x00026; editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. HM-U and JR-S acknowledge, respectively, Grants A1-S-8125 and FC-1132 given by CONAHCYT, Mexico.</p>
</sec>
<ack><p>AV-L, &#x000C1;J-G, and DO-Z acknowledge a scholarship by CONAHCYT, Mexico.</p>
</ack>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adibhatla</surname> <given-names>R. M.</given-names></name> <name><surname>Hatcher</surname> <given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Phospholipase a2, reactive oxygen species, and lipid peroxidation in cns pathologies</article-title>. <source>BMB Rep</source>. <volume>41</volume>:<fpage>560</fpage>. <pub-id pub-id-type="doi">10.5483/BMBRep.2008.41.8.560</pub-id><pub-id pub-id-type="pmid">18755070</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ammendolia</surname> <given-names>D. A.</given-names></name> <name><surname>Bement</surname> <given-names>W. M.</given-names></name> <name><surname>Brumell</surname> <given-names>J. H.</given-names></name></person-group> (<year>2021</year>). <article-title>Plasma membrane integrity: implications for health and disease</article-title>. <source>BMC Biol</source>. <volume>19</volume>, <fpage>1</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1186/s12915-021-00972-y</pub-id><pub-id pub-id-type="pmid">33849525</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>M. T.</given-names></name> <name><surname>Naguib</surname> <given-names>M.</given-names></name> <name><surname>Warltier</surname> <given-names>D. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Propofol: the challenges of formulation</article-title>. <source>Anesthesiology</source> <volume>103</volume>, <fpage>860</fpage>&#x02013;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200510000-00026</pub-id><pub-id pub-id-type="pmid">16192780</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baumgart</surname> <given-names>T.</given-names></name> <name><surname>Hunt</surname> <given-names>G.</given-names></name> <name><surname>Farkas</surname> <given-names>E. R.</given-names></name> <name><surname>Webb</surname> <given-names>W. W.</given-names></name> <name><surname>Feigenson</surname> <given-names>G. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Fluorescence probe partitioning between lo/ld phases in lipid membranes</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1768</volume>, <fpage>2182</fpage>&#x02013;<lpage>2194</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2007.05.012</pub-id><pub-id pub-id-type="pmid">17588529</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blaskovich</surname> <given-names>M. A. T.</given-names></name> <name><surname>Kavanagh</surname> <given-names>A. M.</given-names></name> <name><surname>Elliott</surname> <given-names>A. G.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Ramu</surname> <given-names>S.</given-names></name> <name><surname>Amado</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The antimicrobial potential of cannabidio</article-title>. <source>Commun. Biol</source>. <volume>4</volume>, <fpage>1</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1038/s42003-020-01530-y</pub-id><pub-id pub-id-type="pmid">33469147</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodro</surname> <given-names>M.</given-names></name> <name><surname>Gudiol</surname> <given-names>C.</given-names></name> <name><surname>Garcia-Vidal</surname> <given-names>C.</given-names></name> <name><surname>Tubau</surname> <given-names>F.</given-names></name> <name><surname>Boix</surname> <given-names>L.</given-names></name> <name><surname>Domingo-Domenech</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant eskape pathogens in cancer patients</article-title>. <source>Suppor. Care Cancer</source> <volume>22</volume>, <fpage>603</fpage>&#x02013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1007/s00520-013-2012-3</pub-id><pub-id pub-id-type="pmid">24170166</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Boskou</surname> <given-names>D.</given-names></name> <name><surname>Blekas</surname> <given-names>G.</given-names></name> <name><surname>Tsimidou</surname> <given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>&#x0201C;Olive oil composition,&#x0201D;</article-title> in <source>Olive oil</source> (<publisher-loc>Elsevier</publisher-loc>), <fpage>41</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.4324/9781003040217</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bueno</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Antimicrobial adjuvants drug discovery, the challenge of avoid the resistance and recover the susceptibility of multidrug-resistant strains</article-title>. <source>J. Microb. Biochem. Technol.</source> <volume>8</volume>, <fpage>169</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.4172/1948-5948.1000281</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname> <given-names>Q.</given-names></name> <name><surname>Singh</surname> <given-names>B.</given-names></name> <name><surname>Peisker</surname> <given-names>K.</given-names></name> <name><surname>Metzendorf</surname> <given-names>N.</given-names></name> <name><surname>Ge</surname> <given-names>X.</given-names></name> <name><surname>Dasgupta</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Organization of ribosomes and nucleoids in <italic>Escherichia coli</italic> cells during growth and in quiescence</article-title>. <source>J. Biol. Chem</source>. <volume>289</volume>, <fpage>11342</fpage>&#x02013;<lpage>11352</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.557348</pub-id><pub-id pub-id-type="pmid">24599955</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>A. C.</given-names></name> <name><surname>Liu</surname> <given-names>B. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Identification of characteristic macromolecules of <italic>Escherichia coli</italic> genotypes by atomic force microscope nanoscale mechanical mapping</article-title>. <source>Nanoscale Res. Lett</source>. <volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1186/s11671-018-2452-2</pub-id><pub-id pub-id-type="pmid">29396772</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dadgostar</surname> <given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Antimicrobial resistance: implications and costs</article-title>. <source>Infect. Drug Resist</source>. <volume>12</volume>:<fpage>3903</fpage>. <pub-id pub-id-type="doi">10.2147/IDR.S234610</pub-id><pub-id pub-id-type="pmid">31908502</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>J.</given-names></name> <name><surname>Davies</surname> <given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Origins and evolution of antibiotic resistance</article-title>. <source>Microbiol. Molec. Biol. Rev</source>. <volume>74</volume>, <fpage>417</fpage>&#x02013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00016-10</pub-id><pub-id pub-id-type="pmid">20805405</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Rosa</surname> <given-names>M. C.</given-names></name> <name><surname>Alinovi</surname> <given-names>C. C.</given-names></name> <name><surname>Galtieri</surname> <given-names>A.</given-names></name> <name><surname>Scatena</surname> <given-names>R.</given-names></name> <name><surname>Giardina</surname> <given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron</article-title>. <source>Gene</source> <volume>398</volume>, <fpage>162</fpage>&#x02013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2007.02.048</pub-id><pub-id pub-id-type="pmid">17573207</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Derby</surname> <given-names>M. C.</given-names></name> <name><surname>Gleeson</surname> <given-names>P. A.</given-names></name></person-group> (<year>2007</year>). <article-title>New insights into membrane trafficking and protein sorting</article-title>. <source>Int. Rev. Cytol</source>. <volume>261</volume>, <fpage>47</fpage>&#x02013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7696(07)61002-X</pub-id><pub-id pub-id-type="pmid">17560280</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devinsky</surname> <given-names>O.</given-names></name> <name><surname>Cross</surname> <given-names>J. H.</given-names></name> <name><surname>Laux</surname> <given-names>L.</given-names></name> <name><surname>Marsh</surname> <given-names>E.</given-names></name> <name><surname>Miller</surname> <given-names>I.</given-names></name> <name><surname>Nabbout</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Trial of cannabidiol for drug-resistant seizures in the dravet syndrome</article-title>. <source>New Engl. J. Med</source>. <volume>376</volume>, <fpage>2011</fpage>&#x02013;<lpage>2020</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1611618</pub-id><pub-id pub-id-type="pmid">28538134</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dons&#x000ED;</surname> <given-names>F.</given-names></name> <name><surname>Annunziata</surname> <given-names>M.</given-names></name> <name><surname>Vincensi</surname> <given-names>M.</given-names></name> <name><surname>Ferrari</surname> <given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Design of nanoemulsion-based delivery systems of natural antimicrobials: effect of the emulsifier</article-title>. <source>J. Biotechnol</source>. <volume>159</volume>, <fpage>342</fpage>&#x02013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.07.001</pub-id><pub-id pub-id-type="pmid">21763730</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gudiol</surname> <given-names>C.</given-names></name> <name><surname>Carratal&#x000E1;</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Antibiotic resistance in cancer patients</article-title>. <source>Expert Rev. Anti Infect. Ther</source>. <volume>12</volume>, <fpage>1003</fpage>&#x02013;<lpage>1016</lpage>. <pub-id pub-id-type="doi">10.1586/14787210.2014.920253</pub-id><pub-id pub-id-type="pmid">24834465</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guzm&#x000E1;n</surname> <given-names>E.</given-names></name> <name><surname>Fern&#x000E1;ndez-Pe&#x000F1;a</surname> <given-names>L.</given-names></name> <name><surname>Rossi</surname> <given-names>L.</given-names></name> <name><surname>Bouvier</surname> <given-names>M.</given-names></name> <name><surname>Ortega</surname> <given-names>F.</given-names></name> <name><surname>Rubio</surname> <given-names>R. G.</given-names></name></person-group> (<year>2021</year>). <article-title>Nanoemulsions for the encapsulation of hydrophobic actives</article-title>. <source>Cosmetics</source> <volume>8</volume>:<fpage>45</fpage>. <pub-id pub-id-type="doi">10.3390/cosmetics8020045</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>A. H.</given-names></name> <name><surname>S&#x000F8;rensen</surname> <given-names>K. T.</given-names></name> <name><surname>Mathieu</surname> <given-names>R.</given-names></name> <name><surname>Serer</surname> <given-names>A.</given-names></name> <name><surname>Duelund</surname> <given-names>L.</given-names></name> <name><surname>Khandelia</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Propofol modulates the lipid phase transition and localizes near the headgroup of membranes</article-title>. <source>Chem. Phys. Lipids</source> <volume>175</volume>, <fpage>84</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemphyslip.2013.08.002</pub-id><pub-id pub-id-type="pmid">23994552</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>L. K.</given-names></name> <name><surname>Theriot</surname> <given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Relative rates of surface and volume synthesis set bacterial cell size</article-title>. <source>Cell</source> <volume>165</volume>, <fpage>1479</fpage>&#x02013;<lpage>1492</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.045</pub-id><pub-id pub-id-type="pmid">27259152</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karami</surname> <given-names>Z.</given-names></name> <name><surname>Zanjani</surname> <given-names>M. R. S.</given-names></name> <name><surname>Hamidi</surname> <given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Nanoemulsions in cns drug delivery: recent developments, impacts and challenges</article-title>. <source>Drug Discov. Today</source> <volume>24</volume>, <fpage>1104</fpage>&#x02013;<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2019.03.021</pub-id><pub-id pub-id-type="pmid">30914298</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname> <given-names>Y.</given-names></name> <name><surname>Jordan</surname> <given-names>O.</given-names></name> <name><surname>Hanawa</surname> <given-names>T.</given-names></name> <name><surname>Borchard</surname> <given-names>G.</given-names></name> <name><surname>Patrulea</surname> <given-names>V.</given-names></name></person-group> (<year>2020</year>). <article-title>Are antimicrobial peptide dendrimers an escape from eskape?</article-title> <source>Adv. Wound Care</source> <volume>9</volume>, <fpage>378</fpage>&#x02013;<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2019.1113</pub-id><pub-id pub-id-type="pmid">32320368</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korkmaz</surname> <given-names>F.</given-names></name> <name><surname>Severcan</surname> <given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Effect of progesterone on dppc membrane: evidence for lateral phase separation and inverse action in lipid dynamics</article-title>. <source>Arch. Biochem. Biophys</source>. <volume>440</volume>, <fpage>141</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2005.06.013</pub-id><pub-id pub-id-type="pmid">16054109</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnamoorthy</surname> <given-names>R.</given-names></name> <name><surname>Athinarayanan</surname> <given-names>J.</given-names></name> <name><surname>Periasamy</surname> <given-names>V. S.</given-names></name> <name><surname>Adisa</surname> <given-names>A. R.</given-names></name> <name><surname>Al-Shuniaber</surname> <given-names>M. A.</given-names></name> <name><surname>Gassem</surname> <given-names>M. A.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Antimicrobial activity of nanoemulsion on drug-resistant bacterial pathogens</article-title>. <source>Microb. Pathog</source>. <volume>120</volume>, <fpage>85</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2018.04.035</pub-id><pub-id pub-id-type="pmid">29684541</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krivic</surname> <given-names>H.</given-names></name> <name><surname>Himbert</surname> <given-names>S.</given-names></name> <name><surname>Sun</surname> <given-names>R.</given-names></name> <name><surname>Feigis</surname> <given-names>M.</given-names></name> <name><surname>Rheinstdter</surname> <given-names>M. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Erythro-pmbs: a selective polymyxin b delivery system using antibody-conjugated hybrid erythrocyte liposomes</article-title>. <source>ACS Infect. Dis</source>. <volume>8</volume>, <fpage>2059</fpage>&#x02013;<lpage>2072</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.2c00017</pub-id><pub-id pub-id-type="pmid">36173819</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Xiao</surname> <given-names>H.</given-names></name> <name><surname>McClements</surname> <given-names>D. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Encapsulation and delivery of crystalline hydrophobic nutraceuticals using nanoemulsions: factors affecting polymethoxyflavone solubility</article-title>. <source>Food Biophys</source>. <volume>7</volume>, <fpage>341</fpage>&#x02013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1007/s11483-012-9272-1</pub-id><pub-id pub-id-type="pmid">23646037</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>J. Y.</given-names></name> <name><surname>May</surname> <given-names>J. M.</given-names></name> <name><surname>Cegelski</surname> <given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Dimethyl sulfoxide and ethanol elicit increased amyloid biogenesis and amyloid-integrated biofilm formation</article-title> in <italic>Escherichia coli. Appl. Environ. Microbiol</italic>. <volume>78</volume>, <fpage>3369</fpage>&#x02013;<lpage>3378</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.07743-11</pub-id><pub-id pub-id-type="pmid">22389366</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname> <given-names>C. A.</given-names></name> <name><surname>Lombardo</surname> <given-names>F.</given-names></name> <name><surname>Dominy</surname> <given-names>B. W.</given-names></name> <name><surname>Feeney</surname> <given-names>P. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title>. <source>Adv. Drug Deliv. Rev</source>. <volume>64</volume>, <fpage>4</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2012.09.019</pub-id><pub-id pub-id-type="pmid">11259830</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname> <given-names>L.</given-names></name> <name><surname>Stellato</surname> <given-names>M. I.</given-names></name> <name><surname>Oliva</surname> <given-names>R.</given-names></name> <name><surname>Falanga</surname> <given-names>A.</given-names></name> <name><surname>Galdiero</surname> <given-names>M.</given-names></name> <name><surname>Petraccone</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Antimicrobial peptides at work: interaction of myxinidin and its mutant WMR with lipid bilayers mimicking the <italic>P. aeruginosa</italic> and <italic>E. coli</italic> membranes</article-title>. <source>Sci. Rep</source>. <volume>7</volume>:<fpage>44425</fpage>. <pub-id pub-id-type="doi">10.1038/srep44425</pub-id><pub-id pub-id-type="pmid">28294185</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malanca</surname> <given-names>L.</given-names></name> <name><surname>Camici</surname> <given-names>M.</given-names></name></person-group> (<year>1989</year>). <article-title>Membrane signals: role of the inositol phosphate system</article-title>. <source>Recenti Prog. Med</source>. <volume>80</volume>, <fpage>621</fpage>&#x02013;<lpage>628</lpage>.</citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malanovic</surname> <given-names>N.</given-names></name> <name><surname>Lohner</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Gram-positive bacterial cell envelopes: the impact on the activity of antimicrobial peptides</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1858</volume>, <fpage>936</fpage>&#x02013;<lpage>946</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2015.11.004</pub-id><pub-id pub-id-type="pmid">26577273</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marza</surname> <given-names>E.</given-names></name> <name><surname>Camougrand</surname> <given-names>N.</given-names></name> <name><surname>Manon</surname> <given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Bax expression protects yeast plasma membrane against ethanol-induced permeabilization</article-title>. <source>FEBS Lett</source>. <volume>521</volume>, <fpage>47</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(02)02819-3</pub-id><pub-id pub-id-type="pmid">12067724</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname> <given-names>P.</given-names></name> <name><surname>Robson</surname> <given-names>P.</given-names></name> <name><surname>Cubala</surname> <given-names>W. J.</given-names></name> <name><surname>Vasile</surname> <given-names>D.</given-names></name> <name><surname>Morrison</surname> <given-names>P. D.</given-names></name> <name><surname>Barron</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial</article-title>. <source>Am. J. Psychiatry</source> <volume>175</volume>, <fpage>225</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2017.17030325</pub-id><pub-id pub-id-type="pmid">29241357</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meincken</surname> <given-names>M.</given-names></name> <name><surname>Holroyd</surname> <given-names>D.</given-names></name> <name><surname>Rautenbach</surname> <given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of <italic>Escherichia coli</italic></article-title>. <source>Antimicrob. Agents Chemother</source>. <volume>49</volume>, <fpage>4085</fpage>&#x02013;<lpage>4092</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.49.10.4085-4092.2005</pub-id><pub-id pub-id-type="pmid">16189084</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mileykovskaya</surname> <given-names>E.</given-names></name> <name><surname>Sun</surname> <given-names>Q.</given-names></name> <name><surname>Margolin</surname> <given-names>W.</given-names></name> <name><surname>Dowhan</surname> <given-names>W.</given-names></name></person-group> (<year>1998</year>). <article-title>Localization and function of early cell division proteins in filamentous <italic>Escherichia coli</italic> cells lacking phosphatidylethanolamine</article-title>. <source>J. Bacteriol</source>. <volume>180</volume>, <fpage>4252</fpage>&#x02013;<lpage>4257</lpage>. <pub-id pub-id-type="doi">10.1128/JB.180.16.4252-4257.1998</pub-id><pub-id pub-id-type="pmid">9696776</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moghimi</surname> <given-names>R.</given-names></name> <name><surname>Ghaderi</surname> <given-names>L.</given-names></name> <name><surname>Rafati</surname> <given-names>H.</given-names></name> <name><surname>Aliahmadi</surname> <given-names>A.</given-names></name> <name><surname>McClements</surname> <given-names>D. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Superior antibacterial activity of nanoemulsion of thymus daenensis essential oil against <italic>E. coli</italic></article-title>. <source>Food Chem</source>. <volume>194</volume>, <fpage>410</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2015.07.139</pub-id><pub-id pub-id-type="pmid">26471573</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Momo</surname> <given-names>F.</given-names></name> <name><surname>Fabris</surname> <given-names>S.</given-names></name> <name><surname>Bindoli</surname> <given-names>A.</given-names></name> <name><surname>Scutari</surname> <given-names>G.</given-names></name> <name><surname>Stevanato</surname> <given-names>R.</given-names></name></person-group> (<year>2002</year>). <article-title>Different effects of propofol and nitrosopropofol on dmpc multilamellar liposomes</article-title>. <source>Biophys. Chem</source>. <volume>95</volume>, <fpage>145</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-4622(02)00003-0</pub-id><pub-id pub-id-type="pmid">11897153</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mozaheb</surname> <given-names>N.</given-names></name> <name><surname>Mingeot-Leclercq</surname> <given-names>M.-P.</given-names></name></person-group> (<year>2020</year>). <article-title>Membrane vesicle production as a bacterial defense against stress</article-title>. <source>Front. Microbiol</source>. <volume>11</volume>:<fpage>600221</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.600221</pub-id><pub-id pub-id-type="pmid">33362747</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>C. J.</given-names></name> <name><surname>Ikuta</surname> <given-names>K. S.</given-names></name> <name><surname>Sharara</surname> <given-names>F.</given-names></name> <name><surname>Swetschinski</surname> <given-names>L.</given-names></name> <name><surname>Aguilar</surname> <given-names>G. R.</given-names></name> <name><surname>Gray</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet</source> <volume>399</volume>, <fpage>629</fpage>&#x02013;<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id><pub-id pub-id-type="pmid">35065702</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>O&#x00027;Neill</surname> <given-names>J.</given-names></name></person-group> (<year>2016</year>). <source>Tackling Drug-Resistant Infections Globally: Final Report and Recommendations</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Wellcome Trust</publisher-name>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname> <given-names>J. G.</given-names></name> <name><surname>Paradiso</surname> <given-names>P.</given-names></name> <name><surname>Serro</surname> <given-names>A. P.</given-names></name> <name><surname>Fernandes</surname> <given-names>A.</given-names></name> <name><surname>Saramago</surname> <given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Interaction of local and general anaesthetics with liposomal membrane models: a QCM-D and DSC study</article-title>. <source>Colloids Surf. B</source> <volume>95</volume>, <fpage>65</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2012.02.027</pub-id><pub-id pub-id-type="pmid">22424911</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname> <given-names>E.</given-names></name> <name><surname>Ceja-Vega</surname> <given-names>J.</given-names></name> <name><surname>Krmic</surname> <given-names>M.</given-names></name> <name><surname>Gamez Hernandez</surname> <given-names>A.</given-names></name> <name><surname>Gudyka</surname> <given-names>J.</given-names></name> <name><surname>Porteus</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Differential interaction of cannabidiol with biomembranes dependent on cholesterol concentration</article-title>. <source>ACS Chem. Neurosci</source>. <volume>13</volume>, <fpage>1046</fpage>&#x02013;<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.2c00040</pub-id><pub-id pub-id-type="pmid">35298887</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x000E9;rez-Isidoro</surname> <given-names>R.</given-names></name> <name><surname>Sierra-Valdez</surname> <given-names>F.</given-names></name> <name><surname>Ruiz-Su&#x000E1;rez</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Anesthetic diffusion through lipid membranes depends on the protonation rate</article-title>. <source>Sci. Rep</source>. <volume>4</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/srep07534</pub-id><pub-id pub-id-type="pmid">25520016</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>P. H.</given-names></name> <name><surname>Renkonen</surname> <given-names>O. V.</given-names></name></person-group> (<year>1985</year>). <article-title>Antimicrobial activity of bupivacaine and morphine</article-title>. <source>Anesthesiology</source> <volume>62</volume>, <fpage>178</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-198502000-00015</pub-id><pub-id pub-id-type="pmid">3918482</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Royce</surname> <given-names>L. A.</given-names></name> <name><surname>Liu</surname> <given-names>P.</given-names></name> <name><surname>Stebbins</surname> <given-names>M. J.</given-names></name> <name><surname>Hanson</surname> <given-names>B. C.</given-names></name> <name><surname>Jarboe</surname> <given-names>L. R.</given-names></name></person-group> (<year>2013</year>). <article-title>The damaging effects of short chain fatty acids on <italic>Escherichia coli</italic> membranes</article-title>. <source>Appl. Microbiol. Biotechnol</source>. <volume>97</volume>, <fpage>8317</fpage>&#x02013;<lpage>8327</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-013-5113-5</pub-id><pub-id pub-id-type="pmid">23912117</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sagalowicz</surname> <given-names>L.</given-names></name> <name><surname>Leser</surname> <given-names>M. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Delivery systems for liquid food products</article-title>. <source>Curr. Opin. Colloid Interf. Sci</source>. <volume>15</volume>, <fpage>61</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.cocis.2009.12.003</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakuragi</surname> <given-names>T.</given-names></name> <name><surname>Yanagisawa</surname> <given-names>K.</given-names></name> <name><surname>Shirai</surname> <given-names>Y.</given-names></name> <name><surname>Dan</surname> <given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>Growth of <italic>Escherichia coli</italic> in propofol, lidocaine, and mixtures of propofol and lidocaine</article-title>. <source>Acta Anaesthesiol. Scand</source>. <volume>43</volume>, <fpage>476</fpage>&#x02013;<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-6576.1999.430418.x</pub-id><pub-id pub-id-type="pmid">10225084</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salinas-Almaguer</surname> <given-names>S.</given-names></name> <name><surname>Angulo-Sherman</surname> <given-names>A.</given-names></name> <name><surname>Sierra-Valdez</surname> <given-names>F. J.</given-names></name> <name><surname>Mercado-Uribe</surname> <given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Sterilization by cooling in isochoric conditions: the case of <italic>Escherichia coli</italic></article-title>. <source>PLoS ONE</source> <volume>10</volume>:<fpage>e0140882</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0140882</pub-id><pub-id pub-id-type="pmid">26480032</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salinas-Almaguer</surname> <given-names>S.</given-names></name> <name><surname>Mell</surname> <given-names>M.</given-names></name> <name><surname>Almendro-Vedia</surname> <given-names>V. G.</given-names></name> <name><surname>Calero</surname> <given-names>M.</given-names></name> <name><surname>Robledo-S&#x000E1;nchez</surname> <given-names>K. C. M.</given-names></name> <name><surname>Ruiz-Suarez</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Membrane rigidity regulates <italic>E. coli</italic> proliferation rates</article-title>. <source>Sci. Rep</source>. <volume>12</volume>:<fpage>933</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-04970-0</pub-id><pub-id pub-id-type="pmid">35042922</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sameni</surname> <given-names>S.</given-names></name> <name><surname>Malacrida</surname> <given-names>L.</given-names></name> <name><surname>Tan</surname> <given-names>Z.</given-names></name> <name><surname>Digman</surname> <given-names>M. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Alteration in fluidity of cell plasma membrane in huntington disease revealed by spectral phasor analysis</article-title>. <source>Sci. Rep</source>. <volume>8</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-19160-0</pub-id><pub-id pub-id-type="pmid">29335600</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000E1;nchez-L&#x000F3;pez</surname> <given-names>E.</given-names></name> <name><surname>Guerra</surname> <given-names>M.</given-names></name> <name><surname>Dias-Ferreira</surname> <given-names>J.</given-names></name> <name><surname>Lopez-Machado</surname> <given-names>A.</given-names></name> <name><surname>Ettcheto</surname> <given-names>M.</given-names></name> <name><surname>Cano</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Current applications of nanoemulsions in cancer therapeutics</article-title>. <source>Nanomaterials</source> <volume>9</volume>:<fpage>821</fpage>. <pub-id pub-id-type="doi">10.3390/nano9060821</pub-id><pub-id pub-id-type="pmid">31159219</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000FC;ttler</surname> <given-names>J.</given-names></name> <name><surname>Ihmsen</surname> <given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>Population pharmacokinetics of propofol: a multicenter study</article-title>. <source>J. Am. Soc. Anesthesiol</source>. <volume>92</volume>, <fpage>727</fpage>&#x02013;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200003000-00017</pub-id><pub-id pub-id-type="pmid">10719952</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seow</surname> <given-names>Y. X.</given-names></name> <name><surname>Yeo</surname> <given-names>C. R.</given-names></name> <name><surname>Chung</surname> <given-names>H. L.</given-names></name> <name><surname>Yuk</surname> <given-names>H.-G.</given-names></name></person-group> (<year>2014</year>). <article-title>Plant essential oils as active antimicrobial agents</article-title>. <source>Crit. Rev. Food Sci. Nutr</source>. <volume>54</volume>, <fpage>625</fpage>&#x02013;<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2011.599504</pub-id><pub-id pub-id-type="pmid">24261536</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shakeel</surname> <given-names>F.</given-names></name> <name><surname>Shafiq</surname> <given-names>S.</given-names></name> <name><surname>Haq</surname> <given-names>N.</given-names></name> <name><surname>Alanazi</surname> <given-names>F. K.</given-names></name> <name><surname>Alsarra</surname> <given-names>I. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview</article-title>. <source>Expert Opin. Drug Deliv</source>. <volume>9</volume>, <fpage>953</fpage>&#x02013;<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1517/17425247.2012.696605</pub-id><pub-id pub-id-type="pmid">22703228</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shevalkar</surname> <given-names>G.</given-names></name> <name><surname>Pai</surname> <given-names>R.</given-names></name> <name><surname>Vavia</surname> <given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Nanostructured lipid carrier of propofol: a promising alternative to marketed soybean oil-based nanoemulsion</article-title>. <source>AAPS PharmSciTech</source> <volume>20</volume>, <fpage>1</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1208/s12249-019-1408-x</pub-id><pub-id pub-id-type="pmid">31139968</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinitzky</surname> <given-names>M.</given-names></name></person-group> (<year>1984</year>). <article-title>Membrane fluidity in malignancy adversative and recuperative</article-title>. <source>Biochim. Biophys. Acta</source> <volume>738</volume>, <fpage>251</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/0304-419X(83)90007-0</pub-id><pub-id pub-id-type="pmid">6097299</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silber</surname> <given-names>N.</given-names></name> <name><surname>Matos de Opitz</surname> <given-names>C. L.</given-names></name> <name><surname>Mayer</surname> <given-names>C.</given-names></name> <name><surname>Sass</surname> <given-names>P.</given-names></name></person-group> (<year>2020</year>). <article-title>Cell division protein ftsz: from structure and mechanism to antibiotic target</article-title>. <source>Future Microbiol</source>. <volume>15</volume>, <fpage>801</fpage>&#x02013;<lpage>831</lpage>. <pub-id pub-id-type="doi">10.2217/fmb-2019-0348</pub-id><pub-id pub-id-type="pmid">32692252</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skaug</surname> <given-names>M. J.</given-names></name> <name><surname>Longo</surname> <given-names>M. L.</given-names></name> <name><surname>Faller</surname> <given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>The impact of texas red on lipid bilayer properties</article-title>. <source>J. Phys. Chem. B</source> <volume>115</volume>, <fpage>8500</fpage>&#x02013;<lpage>8505</lpage>. <pub-id pub-id-type="doi">10.1021/jp203738m</pub-id><pub-id pub-id-type="pmid">21644587</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strahl</surname> <given-names>H.</given-names></name> <name><surname>Hamoen</surname> <given-names>L. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Membrane potential is important for bacterial cell division</article-title>. <source>Proc. Nat. Acad. Sci</source>. <volume>107</volume>, <fpage>12281</fpage>&#x02013;<lpage>12286</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1005485107</pub-id><pub-id pub-id-type="pmid">20566861</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudhahar</surname> <given-names>C.</given-names></name> <name><surname>Haney</surname> <given-names>R.</given-names></name> <name><surname>Xue</surname> <given-names>Y.</given-names></name> <name><surname>Stahelin</surname> <given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Cellular membranes and lipid-binding domains as attractive targets for drug development</article-title>. <source>Curr. Drug Targets</source> <volume>9</volume>, <fpage>603</fpage>&#x02013;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.2174/138945008785132420</pub-id><pub-id pub-id-type="pmid">18691008</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Summer</surname> <given-names>K.</given-names></name> <name><surname>Browne</surname> <given-names>J.</given-names></name> <name><surname>Hollanders</surname> <given-names>M.</given-names></name> <name><surname>Benkendorff</surname> <given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>Out of control: The need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (dmso)</article-title>. <source>Biofilm</source> <volume>4</volume>:<fpage>100081</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioflm.2022.100081</pub-id><pub-id pub-id-type="pmid">36060119</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tayeb</surname> <given-names>H. H.</given-names></name> <name><surname>Moqaddam</surname> <given-names>S. A.</given-names></name> <name><surname>Hasaballah</surname> <given-names>N. H.</given-names></name> <name><surname>Felimban</surname> <given-names>R. I.</given-names></name></person-group> (<year>2022</year>). <article-title>Development of nanoemulsions for the delivery of hydrophobic and hydrophilic compounds against carbapenem-resistant klebsiella pneumoniae</article-title>. <source>RSC Adv</source>. <volume>12</volume>, <fpage>26455</fpage>&#x02013;<lpage>26462</lpage>. <pub-id pub-id-type="doi">10.1039/D2RA03925G</pub-id><pub-id pub-id-type="pmid">36275094</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tayeb</surname> <given-names>H. H.</given-names></name> <name><surname>Sainsbury</surname> <given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Nanoemulsions in drug delivery: formulation to medical application</article-title>. <source>Nanomedicine</source> <volume>13</volume>, <fpage>2507</fpage>&#x02013;<lpage>2525</lpage>. <pub-id pub-id-type="doi">10.2217/nnm-2018-0088</pub-id><pub-id pub-id-type="pmid">30265218</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terjung</surname> <given-names>N.</given-names></name> <name><surname>L&#x000F6;ffler</surname> <given-names>M.</given-names></name> <name><surname>Gibis</surname> <given-names>M.</given-names></name> <name><surname>Hinrichs</surname> <given-names>J.</given-names></name> <name><surname>Weiss</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Influence of droplet size on the efficacy of oil-in-water emulsions loaded with phenolic antimicrobials</article-title>. <source>Food Funct</source>. <volume>3</volume>, <fpage>290</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1039/C2FO10198J</pub-id><pub-id pub-id-type="pmid">22183117</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theuretzbacher</surname> <given-names>U.</given-names></name> <name><surname>Outterson</surname> <given-names>K.</given-names></name> <name><surname>Engel</surname> <given-names>A.</given-names></name> <name><surname>Karl&#x000E9;n</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>The global preclinical antibacterial pipeline</article-title>. <source>Nat. Rev. Microbiol</source>. <volume>18</volume>, <fpage>275</fpage>&#x02013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-019-0288-0</pub-id><pub-id pub-id-type="pmid">31745331</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname> <given-names>H.</given-names></name></person-group> (<year>2001</year>). <article-title>Structure-specific membrane-fluidizing effect of 3propofol</article-title>. <source>Clin. Exper. Pharmacol. Physiol</source>. <volume>28</volume>, <fpage>292</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1046/j.1440-1681.2001.03441.x</pub-id><pub-id pub-id-type="pmid">11251643</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaara</surname> <given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Agents that increase the permeability of the outer membrane</article-title>. <source>Microbiol. Rev</source>. <volume>56</volume>, <fpage>395</fpage>&#x02013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1128/mr.56.3.395-411.1992</pub-id><pub-id pub-id-type="pmid">1406489</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veatch</surname> <given-names>S. L.</given-names></name> <name><surname>Keller</surname> <given-names>S. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Seeing spots: complex phase behavior in simple membranes</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1746</volume>, <fpage>172</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2005.06.010</pub-id><pub-id pub-id-type="pmid">16043244</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Cork</surname> <given-names>R.</given-names></name> <name><surname>Rao</surname> <given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Development of a new generation of propofol</article-title>. <source>Curr. Opin. Anesthesiol</source>. <volume>20</volume>, <fpage>311</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1097/ACO.0b013e3281667777</pub-id><pub-id pub-id-type="pmid">17620837</pub-id></citation></ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname> <given-names>M.</given-names></name> <name><surname>Chiriac</surname> <given-names>A. I.</given-names></name> <name><surname>Otto</surname> <given-names>A.</given-names></name> <name><surname>Zweytick</surname> <given-names>D.</given-names></name> <name><surname>May</surname> <given-names>C.</given-names></name> <name><surname>Schumacher</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Small cationic antimicrobial peptides delocalize peripheral membrane proteins</article-title>. <source>Proc. Nat. Acad. Sci</source>. <volume>111</volume>, <fpage>E1409</fpage>&#x02013;<lpage>E1418</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1319900111</pub-id><pub-id pub-id-type="pmid">24706874</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitehead</surname> <given-names>K. A.</given-names></name> <name><surname>Rogers</surname> <given-names>D.</given-names></name> <name><surname>Colligon</surname> <given-names>J.</given-names></name> <name><surname>Wright</surname> <given-names>C.</given-names></name> <name><surname>Verran</surname> <given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Use of the atomic force microscope to determine the effect of substratum surface topography on the ease of bacterial removal</article-title>. <source>Coll. Surf. B</source> <volume>51</volume>, <fpage>44</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2006.05.003</pub-id><pub-id pub-id-type="pmid">16822658</pub-id></citation></ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Leser</surname> <given-names>M. E.</given-names></name> <name><surname>Sher</surname> <given-names>A. A.</given-names></name> <name><surname>McClements</surname> <given-names>D. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Formation and stability of emulsions using a natural small molecule surfactant: quillaja saponin (q-naturale<sup>&#x000AE;</sup>)</article-title>. <source>Food Hydrocoll</source>. <volume>30</volume>, <fpage>589</fpage>&#x02013;<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodhyd.2012.08.008</pub-id></citation>
</ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>Z.</given-names></name> <name><surname>Davis</surname> <given-names>R. M.</given-names></name> <name><surname>Kishony</surname> <given-names>R.</given-names></name> <name><surname>Kahne</surname> <given-names>D.</given-names></name> <name><surname>Ruiz</surname> <given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Regulation of cell size in response to nutrient availability by fatty acid biosynthesis</article-title> in <italic>Escherichia coli. Proc. Nat. Acad. Sci</italic>. <volume>109</volume>, <fpage>E2561</fpage>&#x02013;<lpage>E2568</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1209742109</pub-id><pub-id pub-id-type="pmid">22908292</pub-id></citation></ref>
<ref id="B74">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>Q.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Wan</surname> <given-names>Q.</given-names></name> <name><surname>Qiao</surname> <given-names>B.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Frequency and clinical outcomes of eskape bacteremia in solid organ transplantation and the risk factors for mortality</article-title>. <source>Transp. Infect. Dis</source>. <volume>16</volume>, <fpage>767</fpage>&#x02013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1111/tid.12278</pub-id><pub-id pub-id-type="pmid">25124187</pub-id></citation></ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Zhao</surname> <given-names>X.</given-names></name> <name><surname>Yu</surname> <given-names>G.</given-names></name> <name><surname>Suo</surname> <given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Optimization of propofol loaded niosomal gel for transdermal delivery</article-title>. <source>J. Biomater. Sci</source>. <volume>32</volume>, <fpage>858</fpage>&#x02013;<lpage>873</lpage>. <pub-id pub-id-type="doi">10.1080/09205063.2021.1877064</pub-id><pub-id pub-id-type="pmid">33538243</pub-id></citation></ref>
</ref-list>
</back>
</article>